Axios on MSN
Longevity medicine's do-or-die moment
The world's first human trial of whether a drug can essentially make a person's cells younger sets up a reality check for one ...
Researchers are decoding how signals move between body and brain, with implications for how we understand and treat ...
Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
Test time has arrived: the first person has been treated in a highly anticipated gene therapy trial that aims to coax aged ...
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation. Researchers at Lund University have now created ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results